Ƶ

[Skip to Navigation]
Sign In
Correction
18, 2024

Error in Figure

JAMA Oncol. Published online April 18, 2024. doi:10.1001/jamaoncol.2024.1062

The Original Investigation titled “Noninferiority of Hypofractionated vs Conventional Postprostatectomy Radiotherapy for Genitourinary and Gastrointestinal Symptoms: the NRG-GU003 Phase 3 Randomized Clinical Trial,”1 published online March 14, 2024, contained an error in the y-axis of Figure 2. The correct measurement is the percentage of patients with grade 3 or higher adverse events. This article was corrected online.

Reference
1.
Buyyounouski  MK, Pugh  SL, Chen  RC,  et al.  Noninferiority of hypofractionated vs conventional postprostatectomy radiotherapy for genitourinary and gastrointestinal symptoms: the NRG-GU003 phase 3 randomized clinical trial.   JAMA Oncol. Published online March 14, 2024. doi:
×